Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PHAT

Phathom Pharmaceuticals Inc

Apr 30 • 12:24PM ET

10.85

-0.93 -7.89 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NBIX BPMC AXSM BTAI ACAD VKTX MDGL PTGX RDUS XENE

| Held by: VTI IWM VXF XPH IBB IWN SURI SCHA VTWO VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.05	Insider Own	37.29%	Shs Outstand	71.42M	Perf Week	-10.77%
Market Cap	861.82M	Forward P/E	7.96	EPS next Y	1.36	Insider Trans	-0.00%	Shs Float	49.81M	Perf Month	-2.34%
Enterprise Value	1.32B	PEG	-	EPS next Q	-0.16	Inst Own	47.66%	Short Float	19.08%	Perf Quarter	-19.81%
Income	-221.25M	P/S	4.92	EPS this Y	90.33%	Inst Trans	5.12%	Short Ratio	8.52	Perf Half Y	-19.87%
Sales	175.11M	P/B	-	EPS next Y	565.15%	ROA	-69.33%	Short Interest	9.50M	Perf YTD	-34.60%
Book/sh	-6.14	P/C	6.63	EPS next 5Y	-	ROE	-	52W High	18.31 -40.74%	Perf Year	152.91%
Cash/sh	1.64	P/FCF	-	EPS past 3/5Y	15.64% 4.82%	ROIC	-179.72%	52W Low	2.21 390.95%	Perf 3Y	1.40%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	87.09%	Volatility	7.77% 6.28%	Perf 5Y	-71.83%
Dividend TTM	-	EV/Sales	7.54	EPS Y/Y TTM	43.00%	Oper. Margin	-91.36%	ATR (14)	0.88	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.69	Sales Y/Y TTM	216.93%	Profit Margin	-126.35%	RSI (14)	40.34	Recom	1.30
Dividend Gr. 3/5Y	- -	Current Ratio	1.73	EPS Q/Q	72.66%	SMA20	-10.57%	Beta	0.61	Target Price	23.70
Payout	-	Debt/Eq	-	Sales Q/Q	94.12%	SMA50	-5.86%	Rel Volume	3.81	Prev Close	11.78
Employees	371	LT Debt/Eq	-	Earnings	Apr 30 BMO	SMA200	-13.50%	Avg Volume	1.12M	Price	10.85
IPO	Oct 25, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	38.04% 4.29%	Trades		Volume	2,011,663	Change	-7.89%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)